Treatment of dysmenorrhea and migraine symptoms
US4024279A · kind A · utility
10Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 24, 1975 |
| Grant date | May 17, 1977 |
| Priority date | — |
| Expiry date | Jul 24, 1995 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/195
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition for the treatment of, or for the alleviation of primary dysmenorrhea, for the treatment of acute migraine and for attaining the relaxation of smooth muscle, and a process for the treatment of the above afflictions, comprising as active ingredient a pharmaceutically active dosage of an inhibitor of prostaglandin synthetase and action. The active ingredient of choice is flufenamic acid, meferamic acid, meclofenamic acid or niflumic acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.